About Ansa Biotechnologies
Ansa Biotechnologies is a private company based in Emeryville, California. It has reported $124,183,858 raised in four offerings on Form D since July 2020. Its chief executive is Jason Gammack.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 28, 2024 | Oct 2, 2025amended Dec 10, 2025 | $46,449,665of $56.9M target | 41 | $1.1M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 18, 2022 | Apr 14, 2022amended May 5, 2022 | $67,999,951of $76.6M target | 28 | $2.4M | Equity, DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 8, 2021 | Oct 15, 2021 | $5,000,000fully sold | 7 | $714K | Equity, DebtRule 506(b) | Form D ↗ |
| Jun 24, 2020 | Jul 9, 2020 | $4,734,242of $9.2M target | 24 | $197K | Equity, Debt, Series Seed-1 Pfd Stock, Series Seed-2 Prd Stock, Series Seed-3 Pfd Stock, Series Seed-4 Pfd Stock, Series Seed-5 Pfd Stock, and Simple Agreements for Future Equity ("SAFES") and the underlying shares of Common Stock issuable upon the conversion thereof.Rule 506(b) | Form D ↗ |
| Total, four offerings | $124,183,858 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ansa Biotechnologies's Form D filed Dec 10, 2025.
JG
Jason Gammack
Chief Executive Officer and director
YD
Yanniv Dorone
Director
DA
Daniel Lin-Arlow
Executive officer and director
CZ
Chenny Zhang
Director
MM
Matthew McManus
Director
SP
Sebastian Palluk
Executive officer
Earlier filings also listed Lily Li (director, last listed May 2022).